Ok, I am now abit confused, but also very pleased.
Reading over Alteritys last shareholder news letter released in January. I must have misread this section, but ATH434 has already been given orphan drug designation for the treatment for MSA.
Therefore, would I be correct in saying that this drug will be given the green light even if results remain the same/replicated from the 202 study in the 201 study ?.
Thoughts and/or further insight would be appreciated.
- Forums
- ASX - By Stock
- ATH
- What to hopefully look forward too
What to hopefully look forward too, page-16
-
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $32.63K | 10.83M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 21801548 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 130971725 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 20227248 | 0.003 |
71 | 92135679 | 0.002 |
30 | 140776398 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 130971725 | 28 |
0.005 | 18848455 | 22 |
0.006 | 22089363 | 18 |
0.007 | 53073650 | 24 |
0.008 | 43655463 | 32 |
Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |